This article was originally published in RAJ Devices
Regulation bans dura mater and stipulates device reprocessing requirements
You may also be interested in...
Plaintiff Peter Lurie, former US FDA associate commissioner, expects results of hundreds of clinical trials of approved drugs will become available under ruling against HHS; co-plaintiff sought eteplirsen study data.
US HHS Office of Inspector General clears company program to provide travel expenses and lodging to needy patients located far from designated treatment centers.